LDR | |
01041nam a2200265 a 4500 |
001 |
|
102441214 |
003 |
|
MiAaHDL |
005 |
|
20180731000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
990204s1997 mau rb 000 0 eng d |
035 |
⊔ |
⊔ |
‡asdr-ucbk.b151772939
|
035 |
⊔ |
⊔ |
‡aGLADN151825224
|
040 |
⊔ |
⊔ |
‡aCU
‡cCU
|
043 |
⊔ |
⊔ |
‡an-us---
|
090 |
⊔ |
⊔ |
‡aRC280.B8
‡bM36 1997a
|
035 |
⊔ |
⊔ |
‡a(OCoLC)42036676
|
100 |
1 |
⊔ |
‡aMcClellan, Mark B.
|
245 |
1 |
0 |
‡aBreast cancer :
‡btreatment, outcomes, and cost-effectiveness /
‡cprincipal investigator, Mark B. McClellan.
|
260 |
⊔ |
⊔ |
‡aCambridge, Mass. :
‡bNational Bureau of Economic Research,
‡c[1997]
|
300 |
⊔ |
⊔ |
‡a9 leaves ;
‡c28 cm.
|
500 |
⊔ |
⊔ |
‡a"Grant number DAMD17-96-1-6017."
|
504 |
⊔ |
⊔ |
‡aIncludes bibliographical references (leaf 9).
|
533 |
⊔ |
⊔ |
‡aPhotocopy.
‡bSpringfield, VA :
‡cNational Technical Information Service,
‡d1997.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
0 |
‡aBreast
‡xCancer
‡xTreatment
‡zUnited States.
|
CID |
⊔ |
⊔ |
‡a102441214
|
DAT |
0 |
⊔ |
‡a19180715000000.0
‡b20180731000000.0
|
DAT |
1 |
⊔ |
‡a20180728090539.0
‡b2024-04-30T17:58:17Z
|
DAT |
2 |
⊔ |
‡a2024-04-30T17:30:02Z
|
CAT |
⊔ |
⊔ |
‡aSDR-UCBK
‡dIII - MILLENIUM
‡lprepare.pl-004-007
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-ucbk.b151772939
‡auc1
‡bSDR
‡cUCBK
‡puc1.c066935188
‡sUC
‡1.b151772939
|
974 |
⊔ |
⊔ |
‡bUC
‡cUCBK
‡d20240430
‡sgoogle
‡uuc1.c066935188
‡y1997
‡ric
‡qbib
‡tUS bib date1 >= 1929
|